Higher expression of oncoproteins c-myc, c-erbB-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors
- 1 November 1996
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 3 (6), 574-579
- https://doi.org/10.1007/bf02306092
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- DNA flow-cytometric analysis in colorectal cancer: A comparison of metastasizing and non-metastasizing tumoursJournal of Gastroenterology and Hepatology, 1996
- Allelic Loss of Chromosome 18q and Prognosis in Colorectal CancerNew England Journal of Medicine, 1994
- Relationship among p53, stage, and prognosis of large bowel cancerDiseases of the Colon & Rectum, 1994
- Correlation of p53 with the clinicopathologic features and prognosis of colorectal adenocarcinomaSurgery Today, 1994
- Immunohistochemical Detection of c-myc Products in Colorectal Cancer and Proliferative Cell RateOncology, 1992
- The Circadian Rhythm of Biliary ColicJournal of Clinical Gastroenterology, 1990
- A genetic model for colorectal tumorigenesisCell, 1990
- Immunohistochemical demonstration of altered intracellular localization of the c‐Myc oncogene product in human colorectal neoplasmsThe Journal of Pathology, 1990
- Growth Dominance of the Metastatic Cancer Cell: Cellular and Molecular AspectsAdvances in Cancer Research, 1990
- Biological Diversity in Metastatic Neoplasms: Origins and ImplicationsScience, 1982